What are Envita's Outcome and Response Rates?
Typically, patients who come to Envita Medical Centers and Center of Excellence have advanced cancers that are difficult to treat or they have already failed standard cancer treatments. Dr. Dino Prato and Dr. John Oertle explain how Envita's precision oncology algorithms have helped many of their patients respond to care, despite failing to experience results through standard healthcare's conventional oncology treatments. Envita's focus on precision in the areas of genomic testing, treatment, and chemo and immunotherapy agent selection, is constantly raising the bar in cancer care!
Disclaimer: Individual results will vary. Envita makes no guarantees for outcomes. Each patient case is unique. Please consult your doctor before making any changes to your medical treatment. Not every patient is a candidate for care or achieves these results. Treatments used in this case may not all be FDA approved for the treatment of this condition.
Cancer patients at Envita get the advantage of utilizing the benefits of advanced precision treatment programs, which go beyond the one-size-fits-all protocols, based on cancer type and stage. With precision medicine, we aim to enhance treatment options for cancer patients, and give them an optimal chance at responding to care. Our providers utilize advanced metrics to measure patient's response rates, which include several parameters like the impact of our treatments on patients' tumors and their overall symptom score improvements.
A detailed analysis of the response data of patients who completed care at Envita, showed that 88% of them reported symptom score improvement with 95% fewer side effects*. This level of optimistic response rates even in late-stage cancer patients are a result of practicing precision oncology care, which allows a deeper understanding of each patient's cancer and the factors influencing its growth and spread. Equipped with this detailed knowledge, our specially trained physicians, custom develop a comprehensive treatment plan for each individual patient to precisely target their cancerous cells, while bolstering their immune system for lasting outcomes.
Without such precision treatment plans, outcomes and response rates in late-stage cancers can be so dismal, that these reports usually do not get published at all.
Contact our dedicated medical team, consisting of highly skilled oncologists, interventional radiologists, researchers, and pharmacists, who work together to provide a distinctive approach to cancer treatment. Equipped with rigorous training, our team embraces a personalized precision approach tailored to your needs. We integrate cutting-edge naturopathic and conventional treatment methods, backed by extensive research, to maximize your chances of positive outcomes. Whether you or someone you care about is battling cancer or a chronic illness, please reach out to us at 866-830-4576. May God bless you on your journey to healing.
*Data is based on our analysis of records for 87 out of 129 patients that participated in Envita's treatment program in 2020. 42 patients were removed from the cohort due to the patient's inability to start or complete Envita's prescribed treatment for a variety of reasons, including but not limited to, advanced disease state, disease progression, or inability to travel.
